Hal Wolf announced as new CEO, president of HIMSS

Hal Wolf, previous director with the Chartis Group, has been announced as the new CEO at HIMSS. Wolf replaces Stephen Lieber who held the position for 17 years.

Lieber announced he would be retiring in late 2016. Prior to his years with Chartis, Wolf was the senior vice president and chief operating officer of Kaiser Permanente’s Permanente Federation, where worked in the development of delivery strategies, data management and governance, population care management and the implementation of innovative technologies.

“He sees and creates opportunities, brings people together, and facilitates their success in creating new and better products and services. We are excited that he will be focusing his full energy and efforts to lead HIMSS, as it advances its vision of improving health through information technology and its mission to globally lead endeavors optimizing health engagements and care outcomes through information technology,” said Sebastian Krolop, former HIMSS Board Chair.

This is not the first time Wolf has been associated with HIMSS. He has served as both an advisor to and member of its board and its vice chair for 2016-17..

"Hal Wolf brings to his new role as president and CEO of HIMSS the powerful combination of broad, deep and relevant knowledge, expertise, experience, energy and accomplishments, along with a deep love of and longstanding commitment to HIMSS," said Michael Zaroukian, MD, HIMSS board chair. "His track record of innovation and success spans premier healthcare delivery organizations, digital strategy groups, media companies, global endeavors and more."

“It is a great privilege and honor to be chosen to lead HIMSS, an organization whose purpose is to improve healthcare and care outcomes. Across the globe, healthcare is challenged to harness the power of information and technology, to solve for the unique environments of each health system and to support the personalization of care to the individual. In alliance with the growing membership of HIMSS and the expansive capabilities of our organization, our collective task is to enable innovation across the full healthcare ecosystem,” said Wolf.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.